How Tumors Avoid Immune Detection
Author Information
Author(s): Walter W, Lingnau K, Schmitt E, Loos M, Maeurer M J
Primary Institution: Johannes Gutenberg University, Mainz, Germany
Hypothesis
Qualitative differences in the MHC class II antigen processing and presentation pathway may be instrumental in shaping the CD4+ T cell response directed against tumour cells.
Conclusion
Murine tumor cell lines exhibit different patterns of MHC class II and CIITA expression, which may affect how CD4+ T cells recognize cancer cells.
Supporting Evidence
- Murine MHC class II and H2-M genes are regulated by T helper cell cytokines.
- Different murine tumor cell lines show varying levels of MHC class II and CIITA expression.
- H2-M isoforms equally promote antigen processing for CD4+ T cells.
Takeaway
Some tumors can hide from the immune system by changing how they show their proteins, which can make it harder for the body to fight them.
Methodology
The study used mRNA expression and Western blot analysis to assess MHC class II and H2-M gene regulation in murine tumor cell lines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website